- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04478552
Analgesic Effect of Fascia Iliaca Compartment Block in Geriatric Patients With Hip Fracture
May 21, 2023 updated by: Wan Tze Kit, United Christian Hospital
Randomized Controlled Trial on Analgesic Effect of Pre-operative Fascia Iliaca Compartment Block in Geriatric Patients With Hip Fracture
As population in Hong Kong is aging, incidence of geriatrics hip fractures rises.
Operative treatment for selective patients offers pain control, early mobilization and reduction in medical morbidities and mortalities.
Research has shown that the pain from hip fracture left untreated may have significant physical and psychological effects on the patient, precipitating delirium, especially in elderly patients with hip fractures, and may delay operative management and may complicate hospital stay.
Studies report that the pain management for limb fractures in the elderly is hugely sub-optimal with some suggesting that only 2% receive adequate analgesia.
Adequate analgesia before definitive treatment of hip fracture may improve mobilization and cognitive performance.
As a part of multi-modal pain management, Fascia iliaca compartment block is being increasingly popular as a simple, safe and effective regional technique for patients with hip fractures and proximal femoral shaft fractures, providing consistent analgesic effect for hip fracture patients, irrespective of the performing doctor's experience.
This study aims to provide high level local evidence of the effect and efficacy of the fascia iliaca compartment block in preoperative pain control for patients with hip fracture admitted to Orthopaedic and Traumatology ward in United Christian Hospital.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This study is a randomized control, single blinded trial.
It tests the hypothesis that fascia iliaca compartment block using local anaesthetic agent for pre-operative analgesia in patients with hip fracture, compared to that using normal saline as control, leads to a better pain control and fewer doses of systemic analgesics required.
All patients admitted to United Christian Hospital Orthopaedic and Traumatology ward for hip fracture with radiological diagnosis will be seen by on-call resident.
Principal investigator and other investigators will be notified of the admission within 1 working day.
Subjects will be recruited according to inclusion and exclusion criteria as mentioned in the below section.
Subjects will be recruited only if an informed consent for this study has been signed.
Only patients with hip fracture pending emergency operation will be recruited.
2 enclosed envelopes will be prepared, in which one indicates "intervention", and one indicates "control".
Subjects will randomly choose any of the envelopes without knowing the intervention/control group assignment.
To maintain true randomization, the 2 envelopes will be kept in good condition, preventing identification of the underlying assignment from the outer appearance.
Investigators, knowing the group assignment, will then prepare an injection kit set for Fascia iliaca compartment block which includes vials of levobupivacaine, normal saline, syringes, 22G/21G needle, simple dressing set and skin antiseptic solution.
For the intervention group, fascia iliaca compartment block with 30ml/40ml 0.25% levobupivacaine, depending on body weight (30ml for body weight less than 50kg, 40ml for body weight more than 50kg), will be performed by investigators under landmark approach.
For the control group, same volume of normal saline, instead of levobupivacaine, will injected using the same technique, so that single blinding can be achieved.
Subjects' vital signs will be observed for every 10 minutes for 30 minutes after injection.
Study Type
Interventional
Enrollment (Actual)
80
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Tze Kit Wan, MBBS(HK)
- Phone Number: 852 52156974
- Email: wantkkelvin@gmail.com
Study Locations
-
-
Kowloon
-
Kwun Tong, Kowloon, Hong Kong
- United Christian Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
65 years and older (Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Age 65 or above
- Patients admitted Orthopaedic and Traumatology ward in United Christian Hospital
- Radiographically confirmed unilateral fracture hip
- Patient requiring pre-operative analgesia
- Mentally competent
- Informed consent signed
Exclusion Criteria:
- Age less than 65
- Presence of more than one fracture
- Patient refusal to participating in this study
- Known true allergy or previous anaphylactic reaction to local anaesthetic
- Previous femoral-bypass surgery, or near a graft site.
- Previous surgery over the injection site
- Inflammation, infection, or hernia over the injection site
- INR >1.4
- Platelet count <100x 10^9/L
- Patient on heparin / fondaparinux / rivaroxaban / dabigatran / ticlopidine / clopidogrel / prasugrel / cilostazol
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intervention group
|
It involves injecting local anaesthetic agent (levobupivacaine) into the fascia iliaca compartment of the patient, infiltrating three major nerves that supply the medial, anterior and lateral thigh, namely the femoral and lateral femoral cutaneous nerves.
This procedure can be done with anatomical landmark approach or under image guidance.
|
Placebo Comparator: Control group
|
same volume of normal saline, instead of levobupivacaine, will injected using the same technique.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in pain in terms of Numeric Rating Scale
Time Frame: on admission, just before fascia iliaca compartment block, 1 hour after injection, 12 hour after injection, 24 hour after injection, and 48 hour after injection.
|
Numeric Rating Scale (0-10) whereas 0 is the least pain and 10 is the worst pain
|
on admission, just before fascia iliaca compartment block, 1 hour after injection, 12 hour after injection, 24 hour after injection, and 48 hour after injection.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2019
Primary Completion (Actual)
September 14, 2021
Study Completion (Actual)
October 14, 2021
Study Registration Dates
First Submitted
March 25, 2020
First Submitted That Met QC Criteria
July 15, 2020
First Posted (Actual)
July 20, 2020
Study Record Updates
Last Update Posted (Actual)
May 23, 2023
Last Update Submitted That Met QC Criteria
May 21, 2023
Last Verified
May 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SPv1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hip Fractures
-
Smith & Nephew, Inc.Terminated
-
Carilion ClinicCompleted
-
Texas Tech University Health Sciences Center, El...CompletedHip Fractures (i.e. Femoral Neck or Intertrochanteric Hip Fractures)United States
-
Oslo University HospitalDiakonhjemmet HospitalCompletedHip Fractures | Trochanteric Fractures | Intertrochanteric FracturesNorway
-
Tel-Aviv Sourasky Medical CenterUnknownIntertrochanteric Fractures of the HipIsrael
-
FH ORTHORecruitingHip Fractures | Hip DiseaseFrance
-
Zhenjiang First People's HospitalCompletedHip Fractures | Hip DiseaseChina
-
Bayside HealthCompleted
-
University of Missouri-ColumbiaUniversity of Alabama at Birmingham; Medical College of Wisconsin; University...CompletedHip Fractures | Pelvic Fractures | Acetabular FracturesUnited States
-
Rabin Medical CenterUnknown
Clinical Trials on Fascia iliaca compartment block
-
St. Luke's-Roosevelt Hospital CenterCompletedPain Disorder | Sensory DeficitUnited States
-
Zachary BinderMedical University of South Carolina; University of California, San Diego; Yale... and other collaboratorsRecruitingFemur FractureUnited States, Australia
-
Mansoura UniversityCompleted
-
Kocaeli City HospitalActive, not recruitingPain, Postoperative | Knee Arthroplasty, Total | Peripheral Nerve BlockTurkey
-
Ain Shams UniversityRecruiting
-
SSM Health Bone and Joint Hospital at St AnthonyRecruitingAnalgesiaUnited States
-
Ain Shams UniversityRecruiting
-
University of MinnesotaNot yet recruiting
-
Saint Petersburg State University, RussiaRecruitingPerioperative Analgesia | Hip Dislocation, DevelopmentalRussian Federation
-
The University of Hong KongRecruiting